TAGS prof antonio giordano

The European Brain Research Institute (EBRI), founded by Nobel Prize winner Rita Levi Montalcini, that almost closed for lack of funds, will be funded for the next five years by the China Xiamen Biotech LDT for a total about two million Euros. In essence, an agreement that was signed few days ago will place China and Italy to work together on potential applications of the Nerve Growth Factor... read

The meeting aims to provide an overview of recent developments in translational cancer research. In particular the mechanisms of cell cycle control as a platform for the identification of molecules designed to inhibit cell proliferation in cancer cells will be discussed; more specifically, will discuss the potential anticancer effects of some agents that act as inhibitors of histone... read

While many young people mistakenly believe that hand-rolled cigarettes are less dangerous to smoke than filtered cigarettes, a new study shows that smoking hand-rolled cigarettes has stronger genotoxic and oxidative effects on the metabolism than smoking manufactured filtered-cigarettes. The research was published in the journal Mutation Research. Cigarette smoking is a major cause of human... read

Italy may be proud of the success of a scientific study in the United States, which, once again, reaffirms the professionalism of our researchers in the world. Italian scholars of the Fox Chase Cancer Center in Philadelphia, USA, have discovered a new mechanism used by cells to activate silenced genes. This process is critical in preventing the development of cancer, suggesting the possibility... read

TK (Philadelphia, PA) --Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors. Scientists tested new pyrazolo [3,4-d ]pyrimidine derivative inhibitors of the SRC... read

Professor Giovan Giacomo Giordano passed on July 29 last year. A year after his death we remember the distinguished medical pathologist who has devoted over sixty years of his life to the field of cancer research and to the teaching of Anatomy and Histologic Pathology at the University of Naples. Giovan Giacomo Giordano author and coauthor of over three hundred scientific publications, from... read

A new study shows that there are major differences between oncologists and primary care physicians regarding knowledge, attitudes, and practices required to care for American's 12 million cancer survivors. That is the key finding of the first nationally representative survey of doctors that reveals how these differences pose significant barriers to effective communication and coordination of care... read

Chromoendoscopy associated with high-definition video endoscopy offers the possibility to analyze the spectra of colors in the captured image, using dyes (indigo carmine, methylene blue), and high-definition zooming, to study the mucosa (magnification). This technique becomes essential for the recognition of early stages of dysplasia and intestinal cancers, but becomes crucial in patients at high... read

My first meeting with Professor Giordano occurred on December 14, 1962 when he was a board member at my graduation, and again in 1970 to meet his son Antonio who had seen me at the RAI in a television interview with Albert Sabin and a swarm of children vaccinated against polio. Afterwards, , when he was professor of pathology at the University of Naples and Scientific Director of the Pascale... read

A healthy diet, which is rich in fruits and vegetables, whole grains and legumes and contains limited red meat, preserved meats and sugared beverages, protects against tumor development and recurrences. The right diet can be one “protective” factor against cancer, but lifestyle must always be considered as well. Indeed, it is important to engage in physical activity and avoid alcohol and... read